Loading news...
Campbell and CO Investment Adviser LLC decreased its position in The Pennant Group, Inc. (NASDAQ: PNTG) by 46.7% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 23,672 shares of the company's stock after selling 20,710 shares during the period. Campbell and CO
The Pennant Group (NASDAQ: PNTG - Get Free Report) and Encompass Health (NYSE: EHC - Get Free Report) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, institutional ownership, risk and dividends. Earnings and Valuation This table compares The
An aging population and rising AI adoption position the Zacks Medical - Outpatient and Home Healthcare industry for solid growth. EHC, DVA, OPCH and PNTG stand to benefit.
The Pennant Group, Inc. (PNTG) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, PNTG's 50-day simple moving average crossed above its 200-day simple moving average, known as a "golden cross.
Creative Planning increased its stake in The Pennant Group, Inc. (NASDAQ: PNTG) by 23.6% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 28,125 shares of the company's stock after purchasing an additional 5,364 shares during the period. Creative
Geode Capital Management LLC raised its holdings in The Pennant Group, Inc. (NASDAQ: PNTG) by 4.6% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 832,481 shares of the company's stock after purchasing an additional 36,357 shares during the
Gold formed a small bull pennant near the top of the current leg, reclaiming the 10-day average Tuesday while tagging the long-term upper channel line and a downtrend-line convergence just above $4,159.
The Pennant Group, Inc. (NASDAQ: PNTG - Get Free Report) has received a consensus rating of "Hold" from the five research firms that are covering the company, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average 12-month target price
The average of price targets set by Wall Street analysts indicates a potential upside of 30.7% in The Pennant Group (PNTG). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
The Pennant Group, Inc. ( PNTG ) Q3 2025 Earnings Call November 6, 2025 12:00 PM EST Company Participants Kirk Cheney - Executive VP, General Counsel & Corporate Secretary Brent Guerisoli - CEO & Chairman John Gochnour - President & COO Lynette Walbom - Chief Financial Officer Conference Call Participants David MacDonald - Truist Securities, Inc., Research Division Raj Kumar - Stephens Inc., Research Division Presentation Operator Good day, and thank you for standing by. Welcome to The Pennant Group Third Quarter 2025 Earnings Call.
Although the revenue and EPS for The Pennant Group (PNTG) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
The Pennant Group, Inc. (PNTG) came out with quarterly earnings of $0.3 per share, beating the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.26 per share a year ago.
EAGLE, Idaho, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced that the Company has added a term loan to its credit facility, increasing the facility by $100 million to an aggregate of $350 million. The borrowings are supported by Pennant's existing lending consortium led by Truist Securities.
EAGLE, Idaho, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, announces two significant acquisitions that strengthen its presences in key markets.
Leading individual contributors included utility consulting firm Willdan Group, which posted strong earnings and raised guidance in the quarter. Shares of Impinj, a provider of radio frequency identification technology used in tracking inventory, rose sharply in the quarter. Vital Farms is a provider of specialty eggs and butter from small farms and pasture-raised animals.
EAGLE, Idaho, Oct. 24, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of operating subsidiaries that provide home health, hospice and senior living services, announced today that it expects to issue its third quarter 2025 financial results on Wednesday, November 5, 2025.
EAGLE, Idaho, Oct. 02, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, announced today that on October 1, 2025, it acquired certain operations from UnitedHealth Group Incorporated (“UnitedHealth”). The operations were divested pursuant to UnitedHealth's acquisition of Amedisys Inc. by UnitedHealth's Optum unit.
EAGLE, Idaho, Oct. 02, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, announced today that on October 1, 2025, it acquired certain operations from UnitedHealth Group Incorporated (“UnitedHealth”). The operations were divested pursuant to UnitedHealth's and Amedisys Inc.'s (“Amedisys”) antitrust settlement with the United States Justice Department.